Single nucleotide polymorphisms (SNPs) of CD6 have been associated with susceptibility and/or clinical outcome of several autoimmune diseases, including multiple sclerosis (MS), RA, (SS, inflammatory bowel disease (IBD), Behcet’s disease and psoriasis [88,111]. This evidence concerns the gene CD6 and inflammatory bowel disease.